SPC463
Ómaveloxólón eða lyfjafræðilega viðunandi salt þar af
:
Umsókn:
16.4.2024:
15.5.2024
:
23.4.2038:
Skyclarys
16.4.2024
15.5.2024
23.4.2038
:
EU/1/23/1786:
11.3.2024
:
EU/1/23/1786:
9.2.2024
:
Reata Pharmaceuticals Holdings, LLC:
5320 Legacy Drive, Plano, Texas 75024 US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113 Reykjavík